2007Anesthesia & AnalgesiaRequires access

Sugammadex–Rocuronium Dosing

Aaron F. Kopman

Open publisher page 2 citations

Abstract

To the Editor: In their recent dose-finding study, Groudine et al. (1) note that the molecular weight of sugammadex is 3.6 times that of rocuronium. They postulate that these drugs bind in a 1:1 ratio, and that as a result 1.8 mg/kg sugammadex should encapsulate all the rocuronium administered in a 0.50 mg/kg dose. This hypothesis is perhaps overly simplistic as it does not explain all available clinical data. Following rocuronium 1.2 mg/kg, sugammadex 4.0 mg/kg does not produce prompt and complete neuromuscular block if administered 3 min (2) or 5 min later (3). Until all the data are in, I would suggest that it is premature to suggest that when sugammadex and rocuronium are administered in equimolar amounts that complete reversal of neuromuscular block will necessarily ensue. Aaron F. Kopman, MD Department of Anesthesiology (N.R. 408) Saint Vincent's Hospital Manhattan New York, NY [email protected] or [email protected]

About this research paper

What this paper is about

To the Editor: In their recent dose-finding study, Groudine et al. (1) note that the molecular weight of sugammadex is 3.6 times that of rocuronium. They postulate that these drugs bind in a 1:1 ratio, and that as a result 1.8 mg/kg sugammadex should encapsulate all the rocuronium administered in a 0.50 mg/kg dose. This hypothesis is perhaps overly simplistic as it does not explain all available clinical data. Following rocuronium 1.2 mg/kg, sugammadex 4.0 mg/kg does not produce prompt and complete neuromuscular block if administered 3 min (2) or 5 min later (3). Until all the data are in, I would suggest that it is premature to suggest that when sugammadex and rocuronium are administered in equimolar amounts that complete reversal of neuromuscular block will necessarily ensue. Aaron F. Kopman, MD Department of Anesthesiology (N.R. 408) Saint Vincent's Hospital Manhattan New York, NY [email protected] or [email protected]

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To the Editor: In their recent dose-finding study, Groudine et al. (1) note that the molecular weight of sugammadex is 3.6 times that of rocuronium. They postulate that these drugs bind in a 1:1 ratio, and that as a result 1.8 mg/kg sugammadex should encapsulate all the rocuronium administered in a 0.50 mg/kg dose. This hypothesis is perhaps overly simplistic as it does not explain all available clinical data. Following rocuronium 1.2 mg/kg, sugammadex 4.0 mg/kg does not produce prompt and complete neuromuscular block if administered 3 min (2) or 5 min later (3). Until all the data are in, I would suggest that it is premature to suggest that when sugammadex and rocuronium are administered in equimolar amounts that complete reversal of neuromuscular block will necessarily ensue. Aaron F. Kopman, MD Department of Anesthesiology (N.R. 408) Saint Vincent's Hospital Manhattan New York, NY [email protected] or [email protected]

Key concepts: Rocuronium, Sugammadex, Medicine, Dosing, Anesthesia, Neuromuscular monitoring, Anesthesiology, Neuromuscular Blockade

Related papers

Back to paper searchBrowse research topicsOriginal source
Sugammadex–Rocuronium Dosing — Research Paper | ScholarLens